| Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study) A Durrbach, JM Pestana, T Pearson, F Vincenti, VD Garcia, J Campistol, ... American Journal of Transplantation 10 (3), 547-557, 2010 | 608 | 2010 |
| Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys JOM Pestana, JM Grinyo, Y Vanrenterghem, T Becker, JM Campistol, ... American journal of transplantation 12 (3), 630-639, 2012 | 275 | 2012 |
| Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT … Y Vanrenterghem, B Bresnahan, J Campistol, A Durrbach, J Grinyó, ... Transplantation 91 (9), 976-983, 2011 | 212 | 2011 |
| Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure EF Campos, H Tedesco-Silva, PG Machado, M Franco, ... American journal of transplantation 6 (10), 2316-2320, 2006 | 195 | 2006 |
| Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies CP Larsen, J Grinyó, J Medina-Pestana, Y Vanrenterghem, F Vincenti, ... Transplantation 90 (12), 1528-1535, 2010 | 184 | 2010 |
| Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses H Tedesco-Silva, C Felipe, A Ferreira, M Cristelli, N Oliveira, ... American Journal of Transplantation 15 (10), 2655-2664, 2015 | 171 | 2015 |
| Long-term outcomes in belatacept-versus cyclosporine-treated recipients of extended criteria donor kidneys: final results from BENEFIT-EXT, a phase III randomized study A Durrbach, JM Pestana, S Florman, M Del Carmen Rial, L Rostaing, ... American Journal of Transplantation 16 (11), 3192-3201, 2016 | 149 | 2016 |
| An integrated safety profile analysis of belatacept in kidney transplant recipients J Grinyó, B Charpentier, JM Pestana, Y Vanrenterghem, F Vincenti, ... Transplantation 90 (12), 1521-1527, 2010 | 138 | 2010 |
| Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome M Silva Jr, AR Marra, CAP Pereira, JO Medina-Pestana, LFA Camargo Transplantation 90 (5), 581-587, 2010 | 131 | 2010 |
| Pregnancy after renal transplantation–a five‐yr single‐center experience LG Oliveira, N Sass, JL Sato, KS Ozaki, JO Medina Pestana Clinical transplantation 21 (3), 301-304, 2007 | 100 | 2007 |
| Prolonged delayed graft function is associated with inferior patient and kidney allograft survivals TV de Sandes-Freitas, CR Felipe, WF Aguiar, MP Cristelli, ... PLoS One 10 (12), e0144188, 2015 | 99 | 2015 |
| Risk factors associated with graft loss and patient survival after kidney transplantation KM Harada, EL Mandia-Sampaio, TV de Sandes-Freitas, CR Felipe, ... Transplantation proceedings 41 (9), 3667-3670, 2009 | 97 | 2009 |
| Transplantation with kidneys retrieved from deceased donors with acute renal failure R Klein, NZ Galante, TV de Sandes-Freitas, MF de Franco, ... Transplantation 95 (4), 611-616, 2013 | 87 | 2013 |
| O contexto do transplante renal no Brasil e sua disparidade geográfica JO Medina-Pestana, NZ Galante, KM Harada, VD Garcia, M Abbud-Filho, ... Brazilian Journal of Nephrology 33, 472-484, 2011 | 85 | 2011 |
| Long-term exposure to belatacept in recipients of extended criteria donor kidneys B Charpentier, JOM Pestana, MDC Rial, L Rostaing, J Grinyó, ... American Journal of Transplantation 13 (11), 2884-2891, 2013 | 79 | 2013 |
| Kidney transplantation in Brazil and its geographic disparity JO Medina-Pestana, NZ Galante, KM Harada, VD Garcia, M Abbud-Filho, ... Brazilian Journal of Nephrology 33, 472-484, 2011 | 77 | 2011 |
| High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study LR Requiao-Moura, TV Sandes-Freitas, LA Viana, MP Cristelli, ... PLoS One 16 (7), e0254822, 2021 | 73 | 2021 |
| Circadian and time‐dependent variability in tacrolimus pharmacokinetics SI Park, CR Felipe, PG Pinheiro‐Machado, R Garcia, H Tedesco‐Silva Jr, ... Fundamental & clinical pharmacology 21 (2), 191-197, 2007 | 73 | 2007 |
| Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen GA Spinelli, CR Felipe, SI Park, EL Mandia-Sampaio, H Tedesco-Silva Jr, ... Transplantation proceedings 43 (10), 3730-3737, 2011 | 66 | 2011 |
| Organization of a high-volume kidney transplant program—the “assembly line” approach JO Medina-Pestana Transplantation 81 (11), 1510-1520, 2006 | 65 | 2006 |
Helio Tedesco Silva Junior, MD, PhDFederal University of São PauloVerified email at medfarm.com.br